One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen by Campeotto, I, Goldenzweig, A, Davey, J, Barfod, L, Marshall, J, Silk, S, Wright, K, Draper, S, Higgins, M, Fleishman, S

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5 by Harrison, TE, Alam, N, Farrell, B, Quinkert, D, Lias, AM, King, LDW, Barfod, LK, Draper, SJ, Campeotto, I, Higgins, MK

The structure of the cysteine-rich domain of Plasmodium falciparum P113 identifies the location of the RH5 binding site by Campeotto, I, Galaway, F, Mehmood, S, Barfod, LK, Quinkert, D, Kotraiah, V, Phares, TW, Wright, KE, Snijders, AP, Draper, SJ, Higgins, MK, Wright, GJ

Design of a basigin-mimicking inhibitor targeting the malaria invasion protein RH5. by Warszawski, S, Dekel, E, Campeotto, I, Marshall, JM, Wright, KE, Lyth, O, Knop, O, Regev-Rudzki, N, Higgins, MK, Draper, SJ, Baum, J, Fleishman, SJ

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies by King, LDW, Pulido, D, Barrett, JR, Davies, H, Quinkert, D, Lias, AM, Silk, SE, Pattinson, DJ, Diouf, A, Williams, BG, McHugh, K, Rodrigues, A, Rigby, CA, Strazza, V, Suurbaar, J, Rees-Spear, C, Dabbs, RA, Ishizuka, AS, Zhou, Y, Gupta, G, Jin, J, Li, Y, Carnrot, C, Minassian, AM, Campeotto, I, Fleishman, SJ, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Long, CA, Miura, K, Ashfield, R, Skinner, K, Howarth, MR, Biswas, S, Draper, SJ